Relative circadian disruption in urinary excretion associates with renal function in biopsy-proven primary glomerular diseases: a cross-sectional study using the novel CRDI metric

Apr 13, 2026Renal failure

Changes in daily urine patterns linked to kidney function in primary glomerular disease using a new disruption measure

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

The Circadian Rhythm Disruption Index (CRDI) for creatinine is independently associated with renal function, showing a β of -4.45 mL/min/1.73m per unit increase.

Significant circadian rhythms were confirmed for all biomarkers, including protein, creatinine, and volume.
The CRDI demonstrated a strong inverse association with estimated glomerular filtration rate (eGFR), particularly in patients with IgA nephropathy.
Incorporating CRDI_cr into clinical models improved the ability to identify eGFR ≤60 mL/min/1.73m, with an increase in area under the curve (AUC) from 0.748 to 0.800.
The Circadian Rhythm Disruption Index effectively quantifies circadian disruption in urinary solute excretion.
The findings suggest the potential of CRDI_cr as a novel biomarker for risk stratification in specific primary glomerular diseases.

AI simplified

The circadian rhythmicity of urinary solute excretion is a hallmark of intact renal physiology, yet its disruption in chronic kidney disease (CKD) lacks a practical quantitative tool. We developed the novel Circadian Rhythm Disruption Index (CRDI) to objectively quantify this disruption from routine clinical data and investigated its association with estimated glomerular filtration rate (eGFR) in primary glomerular diseases. This cross-sectional study prospectively enrolled 81 inpatients with biopsy-confirmed primary glomerular diseases under standardized hospital protocols. All spontaneous urine samples over 24-hours were collected. The presence of circadian rhythms in urinary excretion was validated by cosinor analysis. CRDI metrics were defined and developed to calculate protein, creatinine, and volume. Multivariable linear regression was used to examine the CRDI-eGFR relationship, adjusting for demographics, pathology, and medications. Clinical utility was assessed using ROC and decision curve analysis. Significant circadian rhythms were confirmed for all biomarkers. The CRDI for creatinine (CRDI_cr) demonstrated the strongest independent inverse association with eGFR after full adjustment (β = -4.45 mL/min/1.73mper unit, = 0.008). A key finding was the pathological specificity of this relationship; it was most pronounced in IgA nephropathy. Incorporating CRDI_cr into a clinical model improved the AUC for identifying eGFR ≤60 mL/min/1.73mfrom 0.748 to 0.800 and yielded a significant net reclassification improvement (NRI = 0.237). The CRDI effectively quantifies relative circadian disruption. CRDI_cr is independently associated with renal function in a pathology-specific manner, highlighting its potential as a novel biomarker for refined risk stratification in specific glomerular diseases, particularly IgA nephropathy. 2 2p

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text ↗

Relative circadian disruption in urinary excretion associates with renal function in biopsy-proven primary glomerular diseases: a cross-sectional study using the novel CRDI metric

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief